NI PPP authorisations affected by EU upcoming MRL amendments The EU maximum residue levels (MRLs) review programme can result in EU MRLs being lowered and PPPs authorised in NI may be affected. HSE aims to notify authorisation holders when we identify NI PPP authorisations that require amending or withdrawing because of new EU MRLs coming into force. For the latest agreed changes to EU MRLs, HSE has not identified any NI PPP authorisations that will be affected. Find out the status of ongoing and upcoming EU MRL reviews. Future EU MRL amendments: publication expected mid 2025 In February 2025, the EU SCoPAFF (Standing Committee on Plants, Animals, Food and Feed) agreed to changes to EU MRLs for active substances under Regulation (EC) No 396/2005. If these pass scrutiny by the European Parliament and Council, we can expect the publication of EU implementing Regulations for the revised MRLs in the next 4 to 6 months. The MRLs are likely to come into force 6 months following publication. It is expected that EU MRLs will be amended for the active substances:Â - Chlorpropham
- Fuberidazole
- Ipconazole
- Methoxyfenozide
- S-metolachlor
- Triflusulfuron
HSE has not identified any PPP authorisations that will be affected.
Find out which commodities are affected by searching for the active substance in the EU MRL database. Related changes proposed to EU MRLs will shortly appear in the 'not yet applicable' column. The above list of active substances does not include EU MRLs resulting from applications to raise EU MRLs, for example to support new PPP uses, or proposals to list active substances on Annex IV of Regulation (EC) No 396/2005 (actives not subject to MRLs). | 
